Literature DB >> 8875310

Studies of Plasmodium falciparum cytoadherence using immortalized human brain capillary endothelial cells.

J G Prudhomme1, I W Sherman, K M Land, A V Moses, S Stenglein, J A Nelson.   

Abstract

The cytoadherence of Plasmodium falciparum-infected erythrocytes was studied using immortalized human brain capillary endothelial cells. The immortalized cells, denoted as BB19, derived from the human brain endothelium, were transformed with the E6E7 genes of human papilloma virus and retained their endothelial nature, i.e. tubule formation occurred with Matrigel as a substratum and the cells stained positive for Factor VIII-related antigen, or vonWillebrand's factor. Surface expression of ICAM-1, VCAM, E-selectin, and CD36 was demonstrated by immunofluorescence staining with monoclonal antibodies to these ligands. Exposure to cytokines (TNF, IFN gamma, IL-1 alpha, and IL-6) and lipopolysaccharide resulted in an increase in expression of ICAM-1, VCAM, E-selectin, and CD36. The BB19 cells bound P. falciparum-infected red blood cells with both the FCR-3 and the ITO4 strains. Antibodies to CD36 and ICAM-1 partially inhibited the binding of the FCR-3 and the ITO4 lines, respectively. These findings suggest that BB19 cells may be useful in the analysis of receptor-based cytoadherence and sequestration, as well as in the cell biology of microvessel formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8875310     DOI: 10.1016/0020-7519(96)00027-6

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  20 in total

Review 1.  Inflammatory cell trafficking across the blood-brain barrier: chemokine regulation and in vitro models.

Authors:  Yukio Takeshita; Richard M Ransohoff
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

2.  Monocyte migration and LFA-1-mediated attachment to brain microvascular endothelia is regulated by SDF-1 alpha through Lyn kinase.

Authors:  Mobeen Malik; Ying-Yu Chen; Martha F Kienzle; Brian E Tomkowicz; Ronald G Collman; Andrzej Ptasznik
Journal:  J Immunol       Date:  2008-10-01       Impact factor: 5.422

3.  An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus.

Authors:  Shane C McAllister; Ryan L Hanson; Kyleen N Grissom; Sara Botto; Ashlee V Moses
Journal:  J Vis Exp       Date:  2017-08-25       Impact factor: 1.355

4.  Permeability of PEGylated immunoarsonoliposomes through in vitro blood brain barrier-medulloblastoma co-culture models for brain tumor therapy.

Authors:  Abdulghani Al-Shehri; Marco E Favretto; Panayiotis V Ioannou; Ignacio A Romero; Pierre-Olivier Couraud; Babette Barbash Weksler; Terry L Parker; Paraskevi Kallinteri
Journal:  Pharm Res       Date:  2014-09-19       Impact factor: 4.200

5.  Long-term infection and transformation of dermal microvascular endothelial cells by human herpesvirus 8.

Authors:  A V Moses; K N Fish; R Ruhl; P P Smith; J G Strussenberg; L Zhu; B Chandran; J A Nelson
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

Review 6.  Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans.

Authors:  J Lou; R Lucas; G E Grau
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 7.  In vitro modeling of the neurovascular unit: advances in the field.

Authors:  Aditya Bhalerao; Farzane Sivandzade; Sabrina Rahman Archie; Ekram Ahmed Chowdhury; Behnam Noorani; Luca Cucullo
Journal:  Fluids Barriers CNS       Date:  2020-03-16

8.  Integrating in vitro organ-specific function with the microcirculation.

Authors:  Monica L Moya; Steven C George
Journal:  Curr Opin Chem Eng       Date:  2014-02-01       Impact factor: 5.163

9.  The Impact of HIV and Malaria Coinfection: What Is Known and Suggested Venues for Further Study.

Authors:  Sarah Hochman; Kami Kim
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-08-09

10.  The hCMEC/D3 cell line as a model of the human blood brain barrier.

Authors:  Babette Weksler; Ignacio A Romero; Pierre-Olivier Couraud
Journal:  Fluids Barriers CNS       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.